Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PDR Network Following FDA Wishlist In Program That Verifies EHRs Have Drug Safety Operations

This article was originally published in The Pink Sheet Daily

Executive Summary

PDR Network offers a certification program for electronic health records that is focused on drug safety. EHR vendors that demonstrate certain functions will be able to include a “PDR Certified” logo on their websites and other marketing materials, acknowledging a number of features FDA wants to see incorporated into EHRs.

You may also be interested in...



Adverse Event Reporting Included In Draft Electronic Health Record Standards

A draft proposal for stage 3 of standards that health care professionals must meet to demonstrate meaningful use of electronic health records includes an adverse event reporting requirement. Janet Woodcock has highlighted adverse event reporting as an area where the agency hopes to interface with EHRs.

EHRs A Tool For Drug Label Communications, Adverse Event Reporting And Adherence – FDA’s Woodcock

FDA’s vision for electronic health records is being incorporated into a new application launched by PDR Network.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS074103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel